Zhu W, Friedman H, Klein TW
They may cause high blood pressure, mood change, irregular heart rate, stroke, seizures, and heart attacks
Future studies are expected to elucidate the safety and efficacy of 5-amino-1MQ, identifying specific populations that may benefit or experience adverse effects
See more comments To view or add a comment, sign in More Relevant Posts New study finds patients taking GLP-1 receptor agonists, commonly used to treat Type 2 diabetes and obesity, have a significantly lower risk of developing noninfectious uveitis compared with patients not taking the medication
For instance, in a parallel-arm randomized controlled trial, 24-h dietary recall was used, and in the group receiving 14 weeks of CR combined with dietary counseling, the percentage of calories from dietary protein increased significantly compared with liraglutide monotherapy, whereas changes in total energy intake were similar between groups [110]